Main Catalog

Found 88
Sort by
Nexus Conferences
Member $15.00
Non-Member $30.00

Innovative Value-Based Contracting Approaches with Comprehensive Clinical Strategies

Contact Hours: 1.5. Innovative approaches to developing value-based contracts in the market need to be multi-faceted.
Value-Based Contracting
AMCP Annual Meeting
Member $15.00
Non-Member $30.00

Introduction to Gene Therapy: Key Terms, Concepts, and International Perspectives - Annual Meeting 2019

Contact Hours: 1.0 : Gene therapy is an investigational technique that offers exciting promise of curing many debilitating and potentially terminal diseases, such as cystic fibrosis, multiple sclerosis, hemophilia, sickle cell disease, and spinal muscular atrophy.
Gene Therapy
AMCP Annual Meeting
Member Free
Non-Member $30.00

It’s an ART: Formulary and Drug Use Management Strategies for HIV Medications - Annual 2019

Contact Hours: 1.25. As people with HIV age, the focus of disease management places more emphasis on the safety of long-term medication use and managing comorbidities. The advantages of safer, more efficacious medications also come with increased cost.
HIV
AMCP Annual Meeting
Member Free
Non-Member $30.00

Key Forces Driving Change in Oncology

Contact Hours: 1.25. Oncology practice is changing rapidly as new advances in innovation lead to new evidence and testing requirements, as well as treatment guidelines.
Oncology
AMCP Annual Meeting
Member $15.00
Non-Member $30.00

Managing Patients with Hemophilia: A Payer’s Perspective - Annual Meeting 2018

Contact Hours: 1.0. Thanks to significant improvements in the treatment of hemophilia, patients are living longer than ever before, with higher expectations for
near-normal quality of life.
Hemophilia
AMCP Annual Meeting
Member Free
Non-Member $30.00

Measuring Value of an IDN Specialty Pharmacy Therapy Management Program for Biologics

Contact Hours: 1.25: Gene therapy is a promising treatment option for a number of diseases, including inherited disorders, some types of cancer, and certain viral infections. The first gene therapy approvals in the United States occurred in 2017.
Specialty
Nexus Conferences
Member Free
Non-Member $30.00

Medical Benefit Medication Management - Low Hanging Fruit to Complex Strategy - Nexus 2017

Contact Hours: 1.5. Are you up to speed on the latest industry best practices in managing your medical-benefit medications?
Hospital/Health Systems
Nexus Conferences
Member Free
Non-Member $30.00

Medical Oncology Drug Cost Trends and Innovative, Practical Payer Management Strategies - Nexus 2018

Contact Hours: 1.5. Medical oncology drugs represent 35 to 47% percent of total medical benefit drug spend.
Oncology
AMCP Annual Meeting
Member Free
Non-Member $30.00

Medicare Formulary Updates Impact

Contact Hours: 1.25. The Centers for Medicare and Medicaid (CMS) continues to critically evaluate formulary regulations and guidance to help lower drug costs.
Medicare
AMCP Annual Meeting
Member Free
Non-Member $30.00

More than Meets the Eye–Value-Based Contracts are More Prevalent than We Think

Contact Hours: 1.25. As the U.S. health care system evolves from a volume-driven system to one that rewards value, there is growing interest in value-based payment arrangements.
Value-Based Contracting